Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).

被引：1
|
作者：
Krantz, Benjamin A.
Tsui, Dana
Lowery, Maeve Aine
Capanu, Marinela
Yu, Kenneth H.
Kelsen, David Paul
Gedvilaite, Erika
Zhang, Liguo
Selcuklu, S. Duygu
You, Daoqi
Pernicka, Jennifer S. Golia
Do, Richard K. G.
Iacobuzio-Donahue, Christine A.
O'Reilly, Eileen Mary
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：1
相关论文
共 50 条
  • [21] pH Regulatory Transporters in Pancreatic Ductal Adenocarcinoma (PDAC)
    Kong, Su Chii
    Christensen, Sandra
    Hoffmann, Else Kay
    Novak, Ivana
    Pedersen, Stine Falsig
    FASEB JOURNAL, 2013, 27
  • [22] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [23] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Targeted therapy (TT) in patients with KRAS wildtype (WT) pancreatic ductal adenocarcinoma (PDAC) produces durable response
    Mehdi, Maahum
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Szabo, Aniko
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William A.
    Erickson, Beth
    Thapa, Bicky
    Ahmed, Gulrayz
    George, Ben
    Kamgar, Mandana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [25] MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Thalji, Samih Z.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Thomas, James P.
    Christians, Kathleen K.
    Evans, Douglas B.
    Hall, William A.
    Erickson, Beth
    Thapa, Bicky
    Ahmed, Gulrayz
    Yazdanpanah, Omid
    Kurzrock, Razelle
    Aldakkak, Mohammed
    Holden, Mary Beth
    Ben George
    Tsai, Susan
    Oxencis, Carolyn
    McFall, Thomas
    Kamgar, Mandana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16260 - E16260
  • [26] Biomarker detection in pancreatic ductal adenocarcinoma
    Klett, H.
    Klose, M.
    Kowar, S.
    Bronsert, P.
    Kuesters, S.
    Werner, M.
    Christoph, P.
    Busch, H.
    Boerries, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S178
  • [27] Protein biomarker for pancreatic ductal adenocarcinoma
    Burki, Talha K.
    LANCET ONCOLOGY, 2017, 18 (09): : E511 - E511
  • [28] Validation of an artificial intelligence derived histological biomarker for gemcitabine response in resected pancreatic ductal adenocarcinoma (PDAC)
    Krishna, Vrishab
    Krishna, Viswesh
    Tiu, Ekin
    Nimgaonkar, Vivek
    Vrabac, Damir
    Smith, Katelyn
    Joshi, Anirudh
    Singhi, Aatur
    Collisson, Eric
    CANCER RESEARCH, 2022, 82 (22) : 28 - 29
  • [29] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [30] Oral cavity immune response in pancreatic ductal adenocarcinoma (PDAC)
    Marquez, J. P.
    Lucero-Diaz, P. A.
    Matute-Briseno, J. A.
    Rosas-Delgado, M. O.
    Camacho-Hernandez, A.
    Cortez-Vargas, Y.
    Nava-Sanchez, I.
    Montano, G. T.
    Montijo-Fernandez, L. N.
    Perez-Astorga, M. A.
    ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
12345